Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioAge Labs, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BIOA
Nasdaq
2830
bioagelabs.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioAge Labs, Inc.
BioAge Labs, Inc. (BIOA) Loses -67.99% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Jan 2nd, 2025 2:35 pm
BioAge Labs, Inc. (BIOA): A Bull Case Theory
- Dec 27th, 2024 2:18 pm
BioAge and Novartis seek drug targets for ageing-related diseases
- Dec 19th, 2024 10:46 am
BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions
- Dec 18th, 2024 2:00 pm
3 closely watched drugs that failed in the clinic
- Dec 16th, 2024 8:00 am
BioAge halts ongoing Phase II trial of obesity drug due to liver concerns
- Dec 9th, 2024 2:28 pm
Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns
- Dec 9th, 2024 12:41 pm
BioAge shares tumble after decision to halt obesity drug study
- Dec 7th, 2024 11:34 am
BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity
- Dec 6th, 2024 9:35 pm
BioAge Labs to Present at Goldman Sachs “Year-Ahead” Catalyst Clinic
- Dec 5th, 2024 9:30 pm
Why BioAge Labs (BIOA) is the Best All-Time Low Stock to Buy Right Now?
- Dec 4th, 2024 9:47 pm
BioAge Labs to Present at Upcoming Investor Conferences
- Nov 21st, 2024 9:30 pm
BioAge Labs Reports Strong Q3 2024 Achievements
- Nov 13th, 2024 4:01 am
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
- Nov 7th, 2024 9:30 pm
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
- Nov 4th, 2024 2:00 pm
BioAge Labs to Present at Jefferies London Healthcare Conference
- Oct 24th, 2024 1:00 pm
Wall Street analysts initiate coverage of BioAge Labs
- Oct 21st, 2024 2:53 pm
Prediction: These 2 Stocks Could Soar in 2025
- Oct 17th, 2024 1:45 pm
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock
- Oct 12th, 2024 6:31 pm
RA Capital Management, L.P. Acquires New Stake in Bioage Labs Inc
- Oct 8th, 2024 1:10 am
Scroll